The trading price of Coherus Biosciences Inc (NASDAQ:CHRS) closed higher on Friday, March 21, and closing at $1.03, 8.83% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.8901 and $1.03. The company’s P/E
Coherus Biosciences Inc (NASDAQ:CHRS) price on current trading day, rose 2.23% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.91. A look at the stock’s price movement, the close in the last trading session was $0.89, moving
Coherus Biosciences Inc (NASDAQ:CHRS) price closed lower on Monday, March 17, and dropping -0.48% below its previous close. A look at the daily price movement shows that the last close reads $0.92, with intraday deals fluctuated between $0.91 and $0.982. The company’s 5Y monthly beta
Coherus Biosciences Inc (NASDAQ:CHRS) concluded the trading at $0.89 on Thursday, March 13 with a fall of -9.12% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.98 and 5Y monthly beta
Coherus Biosciences Inc (NASDAQ:CHRS) traded at $1.04 at close of the session on Friday, March 07 and made an upward move of 4.52% on its previous day’s price. Coherus Biosciences Inc has a market cap of $120.53 million and is expected to release its quarterly
Coherus Biosciences Inc (NASDAQ:CHRS) shares, rose in value, with the stock price down by -1.90% to the previous day’s close as strong demand from buyers drove the stock to $1.03. Actively observing the price movement in the last trading, the stock closed the session at
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
